logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9951043 B1

PDFFull Text
Date of Patent:
Apr. 24, 2018

Filed:

Feb. 28, 2014

Therapeutic compounds

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Gediminas Brizgys, Menlo Park, CA (US);

Eda Canales, San Mateo, CA (US);

Chien-hung Chou, Dublin, CA (US);

Michael Graupe, Pacifica, CA (US);

Randall L. Halcomb, Foster City, CA (US);

Yunfeng Eric Hu, San Mateo, CA (US);

Scott E. Lazerwith, Burlingame, CA (US);

John O. Link, San Francisco, CA (US);

Qi Liu, Union City, CA (US);

Yafan Lu, Foster City, CA (US);

Roland D. Saito, San Mateo, CA (US);

Scott D. Schroeder, Union City, CA (US);

John R. Somoza, Foster City, CA (US);

Winston C. Tse, Redwood City, CA (US);

Jennifer R. Zhang, Union City, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:

Fish & Richardson P.C.

Primary Examiner:

Matthew P Coughlin

Int. Cl.
CPC ...
C07D 401/12 (2006.01); C07D 401/04 (2006.01); C07D 487/04 (2006.01); C07D 413/14 (2006.01); C07D 491/052 (2006.01); C07D 417/14 (2006.01); C07D 401/14 (2006.01); C07D 471/04 (2006.01); C07D 403/14 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4725 (2006.01); A61K 31/496 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 401/12 (2013.01); A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 413/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/052 (2013.01);
Abstract

Compounds of formula (I) or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.

Find Patent Forward Citations

Loading…